GlassScriptPhysician profile
Yong Ji
NPI 1487064119
$3,626.72
in general payments reported to CMS, 2019-2025
19 companies · $468 in 2025
The $468 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $38.76 · 2022: $1,239 · 2023: $880 · 2024: $1,000 · 2025: $468.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,330 · Education: $19.62.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,329.82 |
| Education | $19.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inari Medical, INC. | $851.82 | 2022-2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Boston Scientific Corporation | $841.30 | 2022-2025 | Avvigo Guidance System, Watchman, Sentinel |
| Edwards Lifesciences Corporation | $462.34 | 2023-2025 | Sapien 3 Ultra Resilia, Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Abbott Laboratories | $341.29 | 2021-2023 | Mitraclip |
| Shockwave Medical, INC | $194.25 | 2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Medtronic, INC. | $177.35 | 2022 | |
| Recor Medical INC | $150.54 | 2024 | Paradise Renal Denervation System |
| Actelion Pharmaceuticals US, INC. | $149.80 | 2023 | Uptravi, Opsumit |
| Novartis Pharmaceuticals Corporation | $109.88 | 2022-2023 | |
| Abiomed | $74.75 | 2023-2024 | Impella |
| Boehringer Ingelheim Pharmaceuticals, INC. | $52.49 | 2023-2024 | Jardiance |
| Emd Serono, INC. | $41.25 | 2023 | Mavenclad |
| Cardiva Medical, INC. | $41.00 | 2024 | Optowire |
| Kiniksa Pharmaceuticals International, Plc | $33.03 | 2024 | Arcalyst |
| Janssen Pharmaceuticals, INC | $29.56 | 2024 | Xarelto |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $19.92 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $19.62 | 2023 | |
| Cardiovascular Systems INC. | $19.12 | 2021 | |
| Chiesi USA, INC. | $17.41 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Yong Ji listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.